Why is Boston Bio falling/rising?

As of 07-Nov, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.75, which represents a decrease of 0.37 or 4.56%. The stock has been underperforming, having fallen consecutively for the last two days and showing a total return of -8.82% over the past week. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume on 06 Nov falling by 59.78% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Boston Bio's short-term performance has significantly lagged behind the benchmark, the Sensex, which has only decreased by 0.86% over the same week. While the Sensex has shown a positive return of 1.57% over the past month, Boston Bio has declined by 10.51% in that timeframe, highlighting its underperformance relative to the market. This disparity suggests that investor sentiment towards Boston Bio is weak compared to the overall market, contributing to the stock's downward trajectory.